Literature DB >> 6259270

A cellular basis for the differences in regulation of synthesis and secretion of ACTH/endorphin peptides in anterior and intermediate lobes of the pituitary.

P A Rosa, P Policastro, E Herbert.   

Abstract

The focus of research in our laboratory over the past few years has been the regulation of synthesis, processing and release of the ACTH/LPH family of peptides. These peptides are derived from a common precursor protein that is found in both the anterior and intermediate lobes of the pituitary (Roberts et al. 1978) and in the hypothalamus (Liotta et al. 1979). In the anterior lobe this protein gives rise to alpha (1-39)ACTH, beta-lipotropin and an N-terminal fragment of undefined function. In addition, a variety of intermediate lobe pituitary peptides can be derived from the precursor by further processing of ACTH and beta-LPH. In this paper we compare the structure of the precursor in the anterior and intermediate lobes of mouse and rat pituitary. Processing of the precursor to its constituent hormones is then contrasted in primary cultures of anterior and intermediate lobe cells using pulse label and pulse chase techniques with radioactive amino acids and sugars. Finally, we discuss the difference in behaviour of anterior and intermediate lobe cells in culture with regard to their rates of secretion and intracellular turnover of hormones and regulation of these processes by hypothalamic factors, glucocorticoids and catecholamines.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6259270     DOI: 10.1242/jeb.89.1.215

Source DB:  PubMed          Journal:  J Exp Biol        ISSN: 0022-0949            Impact factor:   3.312


  11 in total

1.  A radioimmunoassay for N-terminal peptide of chum salmon proopiocortin.

Authors:  A Takahashi; H Kawauchi; T Hirano
Journal:  Fish Physiol Biochem       Date:  1987-03       Impact factor: 2.794

2.  Dopamine D2 receptor expression in the corticotroph cells of the human normal pituitary gland.

Authors:  Rosario Pivonello; Marlijn Waaijers; Johan M Kros; Claudia Pivonello; Cristina de Angelis; Alessia Cozzolino; Annamaria Colao; Steven W J Lamberts; Leo J Hofland
Journal:  Endocrine       Date:  2016-10-13       Impact factor: 3.633

3.  A quantitative approach to trace the corticotrophs in culture after adrenalectomy.

Authors:  G Rappay; G B Makara
Journal:  Histochemistry       Date:  1981

4.  Regulation of the pro-opiomelanocortin mRNA levels in rat pituitary by dopaminergic compounds.

Authors:  C L Chen; F T Dionne; J L Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

5.  Release of beta-lipotropin- and beta-endorphin-like material induced by angiotensin in the conscious rat.

Authors:  U Beuers; G Hertting; W Knepel
Journal:  Br J Pharmacol       Date:  1982-08       Impact factor: 8.739

6.  The effect of reserpine on the pars intermedia of the rat pituitary. An electron-microscopic, fluorescence-histochemical and immunohistochemical study.

Authors:  N Bäck; L Rechardt
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

7.  The effect of isoprenaline on plasma concentrations of immunoreactive beta-endorphin and beta-lipotropin in the conscious rat.

Authors:  W Knepel; H Anhut; D Nutto; G Hertting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-09       Impact factor: 3.000

8.  Glucocorticoids regulate proopiomelanocortin gene expression in vivo at the levels of transcription and secretion.

Authors:  N C Birnberg; J C Lissitzky; M Hinman; E Herbert
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

9.  Bovine pituitary intraglandular colloid fraction F5 localized in the rat endocrine pancreas.

Authors:  W H Boyd
Journal:  Experientia       Date:  1985-01-15

10.  An antibody specific for an endoproteolytic cleavage site provides evidence that pro-opiomelanocortin is packaged into secretory granules in AtT20 cells before its cleavage.

Authors:  J Tooze; M Hollinshead; R Frank; B Burke
Journal:  J Cell Biol       Date:  1987-07       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.